BiOptic Inc. is a biotechnology instrumentation company that develops innovative scientific products for research and clinical applications.
The company was founded in 2004, with a vision of establishing high-quality, value-added and customer-driven OEM/ODM solutions by developing and manufacturing products utilizing Capillary Gel Electrophoresis (CGE) Technology for biotechnology laboratories all over the world.
For the past 7 years, BiOptic has expanded its portfolio of products by developing and introducing several CGE instruments: the Qsep1TM, the Gly-QTM, the Qsep400TM, and most recently, the mini-PCR machine, QampminiTM, that incorporates newly launched innovative Direct-PCR reagent kits.
BiOptic strives to be the leader in the biotechnology industry by providing, easy-to-use and cost-effective CGE-based instruments and to provide innovative technical solutions for the world’s top institutions, government and corporate laboratories.
Let’s Find You an Application That Helps Your Research
“Get a call by our representative to help you find the right genomics application for your research.”